PKR, which inhibits protein synthesis through the phosphorylation of eIF2α, has been suggested to have tumour suppressor properties since a functionally defective PKR has been shown to enhance transformation and tumourigenesis of NIH3T3 cells [33], [34]. The gene discussed is EIF2AK2; the disease is neoplasm.